Licensing of natural killer cells by host major histocompatibility complex class I molecules
2005· article· en· Nature· Immunology and Microbiology
affno abstract
1,296
citations
Works
Every work in the frame. Each row carries the routes that admitted it, because a frame that forgets how it found something cannot be audited.
Route
Field
Type
Language
Year range
to
Screen consensus
Sort
Flags
Screening evidence
Direct labels are sparse and unvalidated. Missing labels are unknown.
1 filter active
705 workspage 1 of 29
ULBPs, Novel MHC Class I–Related Molecules, Bind to CMV Glycoprotein UL16 and Stimulate NK Cytotoxicity through the NKG2D Receptor
2001· article· en· Immunity· Immunology and Microbiology
affno abstract
1,205
citations
A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC
2006· article· en· Nature Genetics· Immunology and Microbiology
affno abstract
776
citations
The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9
2006· article· en· Nature Immunology· Immunology and Microbiology
affno abstract
710
citations
Cutting Edge: The Conversion of Arginine to Citrulline Allows for a High-Affinity Peptide Interaction with the Rheumatoid Arthritis-Associated HLA-DRB1*0401 MHC Class II Molecule
2003· article· en· The Journal of Immunology· Medicine
aff
707
citations
Phagosomes are competent organelles for antigen cross-presentation
2003· article· en· Nature· Immunology and Microbiology
affno abstract
688
citations
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
2011· article· en· Nature· Medicine
afffundno abstract
612
citations
A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules
2005· article· en· Blood· Immunology and Microbiology
aff
561
citations
Allogeneic marrow stromal cells are immune rejected by MHC class I– and class II–mismatched recipient mice
2005· article· en· Blood· Medicine
aff
554
citations
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
2008· article· en· Journal of Clinical Investigation· Immunology and Microbiology
afffund
506
citations
Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection
2009· article· en· Nature Immunology· Immunology and Microbiology
affno abstract
451
citations
Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors
2009· article· en· PLoS ONE· Medicine
aff
435
citations
CD4 cells can be more efficient at tumor rejection than CD8 cells
2007· article· en· Blood· Immunology and Microbiology
afffund
421
citations
Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project
2004· article· en· Blood· Medicine
aff
349
citations
A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis
2005· article· en· Nature Genetics· Immunology and Microbiology
affno abstract
333
citations
A Functional Role of HLA-G Expression in Human Gliomas: An Alternative Strategy of Immune Escape
2002· article· en· The Journal of Immunology· Immunology and Microbiology
fundno aff
328
citations
Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity
2022· letter· en· Cancer Discovery· Medicine
afffund
325
citations
Hypochlorous Acid: A Natural Adjuvant That Facilitates Antigen Processing, Cross-Priming, and the Induction of Adaptive Immunity
2009· article· en· The Journal of Immunology· Immunology and Microbiology
aff
323
citations
Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames
2016· article· en· Nature Communications· Biochemistry, Genetics and Molecular Biology
afffund
280
citations
Understanding the drivers of MHC restriction of T cell receptors
2018· review· en· Nature reviews. Immunology· Immunology and Microbiology
affno abstract
276
citations
MHC Class II Engagement by Its Ligand LAG-3 (CD223) Contributes to Melanoma Resistance to Apoptosis
2011· article· en· The Journal of Immunology· Medicine
aff
262
citations
Dependence of T Cell Antigen Recognition on T Cell Receptor-Peptide MHC Confinement Time
2010· article· en· Immunity· Immunology and Microbiology
afffundno abstract
259
citations
MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation
2008· article· en· Proceedings of the National Academy of Sciences· Immunology and Microbiology
aff
251
citations
Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen
2001· article· en· Journal of Clinical Investigation· Immunology and Microbiology
fundno aff
250
citations
The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients
2023· article· en· Cancer Cell· Medicine
afffund
247
citations